Dana-Farber — Boston, Massachusetts

Dana-Farber is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber has participated in 2 clinical trials.

Therapeutic areas: Locally Advanced or Metastatic Solid Tumor, Head and Neck Neoplasms, Carcinoma, Squamous Cell.

Sponsors: Deciphera Pharmaceuticals, LLC, ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA).

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber?

Dana-Farber has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber conducted?

Dana-Farber has 2 clinical trials on record. Their work covers Locally Advanced or Metastatic Solid Tumor, Head and Neck Neoplasms, Carcinoma, Squamous Cell.

Is Dana-Farber accredited by Crixeo Health?

Dana-Farber has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.